BE788516A
(fr)
|
1971-09-10 |
1973-03-07 |
Lonza Ag |
Procede de fabrication d'esters alcoxyacetylacetiques
|
GB1528382A
(en)
|
1974-12-26 |
1978-10-11 |
Teijin Ltd |
Cyclopentene diols and acyl esters thereof and processes for their preparation
|
DE2658401A1
(de)
|
1976-12-23 |
1978-07-06 |
Merck Patent Gmbh |
Cyclopentan-1-amine, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
|
US4575694A
(en)
|
1984-03-05 |
1986-03-11 |
Allied Corporation |
Coaxial connector
|
DE3900736A1
(de)
|
1989-01-12 |
1990-07-26 |
Hoechst Ag |
Positiv arbeitendes strahlungsempfindliches gemisch enthaltend einen mehrfunktionellen (alpha)-diazo-(beta)-ketoester, verfahren zu dessen herstellung und strahlungsempfindliches aufzeichnungsmaterial enthaltend dieses gemisch
|
US5914331A
(en)
|
1990-02-01 |
1999-06-22 |
Emory University |
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
|
US6703396B1
(en)
|
1990-02-01 |
2004-03-09 |
Emory University |
Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
|
US5204466A
(en)
|
1990-02-01 |
1993-04-20 |
Emory University |
Method and compositions for the synthesis of bch-189 and related compounds
|
DE4014649A1
(de)
|
1990-05-08 |
1991-11-14 |
Hoechst Ag |
Neue mehrfunktionelle verbindungen mit (alpha)-diazo-ss-ketoester- und sulfonsaeureester-einheiten, verfahren zu ihrer herstellung und deren verwendung
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
SE9702772D0
(sv)
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
US5935946A
(en)
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
AU1403099A
(en)
|
1997-11-14 |
1999-06-07 |
Merck & Co., Inc. |
Alpha-1a adrenergic receptor antagonists
|
ATE299499T1
(de)
|
1998-11-09 |
2005-07-15 |
Black James Foundation |
Gastrin und cholecystokinin rezeptor ligande
|
GB2345058A
(en)
|
1998-12-01 |
2000-06-28 |
Cerebrus Pharm Ltd |
Hydroxypyridone compounds useful in the treatment of oxidative damage to the central nervous system
|
CZ20012160A3
(cs)
|
1998-12-25 |
2001-10-17 |
Shionogi & Co., Ltd. |
Heteroaromatické deriváty s inhibiční aktivitou proti HIV integráze
|
AU2001262732A1
(en)
|
2000-06-14 |
2001-12-24 |
Shionogi And Co., Ltd. |
Inhibitor for enzyme having two divalent metal ions as active centers
|
EP3042894A1
(en)
|
2001-08-10 |
2016-07-13 |
Shionogi & Co., Ltd. |
Antiviral agent
|
US20050004180A1
(en)
|
2001-10-03 |
2005-01-06 |
ZOU Dong |
Pyrrolidinone derivatives
|
DK1441735T3
(da)
|
2001-10-26 |
2006-06-12 |
Angeletti P Ist Richerche Bio |
N-substituerede hydroxypyrimidinon-carboxamid-inhibitorer af HIV-integrase
|
WO2003042176A1
(fr)
|
2001-11-13 |
2003-05-22 |
Shiseido Co., Ltd. |
Compose azabicyclo, inhibiteur de metalloprotease matricielle et preparation cutanee
|
US7109186B2
(en)
|
2002-07-09 |
2006-09-19 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
JP2006506352A
(ja)
|
2002-09-11 |
2006-02-23 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼ阻害剤として有用なジヒドロキシピリドピラジン−1,6−ジオン化合物
|
PE20040840A1
(es)
|
2002-11-20 |
2004-12-30 |
Japan Tobacco Inc |
Derivados de 4-oxoquinolina como inhibidores de la integrasa del vih
|
CA2512319A1
(en)
|
2003-01-14 |
2004-08-05 |
Gilead Sciences, Inc. |
Compositions and methods for combination antiviral therapy
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
TW200528440A
(en)
|
2003-10-31 |
2005-09-01 |
Fujisawa Pharmaceutical Co |
2-cyanopyrrolidinecarboxamide compound
|
WO2005074513A2
(en)
|
2004-01-30 |
2005-08-18 |
Merck & Co., Inc. |
N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integrase inhibitors
|
CN101014574A
(zh)
|
2004-03-09 |
2007-08-08 |
默克公司 |
Hiv整合酶抑制剂
|
WO2005110399A2
(en)
|
2004-04-29 |
2005-11-24 |
The Regents Of The University Of California |
Zinc-binding groups for metalloprotein inhibitors
|
WO2006028523A2
(en)
|
2004-04-29 |
2006-03-16 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO USDC Technology Transfer Office |
Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
|
CA2564372C
(en)
|
2004-05-07 |
2011-10-11 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
US7273859B2
(en)
|
2004-05-12 |
2007-09-25 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors: cyclic pyrimidinone compounds
|
US7531554B2
(en)
|
2004-05-20 |
2009-05-12 |
Japan Tobacco Inc. |
4-oxoquinoline compound and use thereof as HIV integrase inhibitor
|
MY134672A
(en)
|
2004-05-20 |
2007-12-31 |
Japan Tobacco Inc |
Stable crystal of 4-oxoquinoline compound
|
EP1758581A1
(en)
|
2004-05-21 |
2007-03-07 |
Japan Tobacco, Inc. |
Combinations comprising a 4-isoquinolone derivative and anti-hiv agents
|
WO2006030807A1
(ja)
|
2004-09-15 |
2006-03-23 |
Shionogi & Co., Ltd. |
Hivインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体
|
WO2006066414A1
(en)
|
2004-12-23 |
2006-06-29 |
Virochem Pharma Inc. |
Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
|
JP5317257B2
(ja)
|
2005-02-21 |
2013-10-16 |
塩野義製薬株式会社 |
Hivインテグラーゼ阻害活性を有する2環性カルバモイルピリドン誘導体
|
KR101848819B1
(ko)
*
|
2005-04-28 |
2018-04-16 |
비이브 헬쓰케어 컴퍼니 |
Hiv 통합효소 억제 활성을 가지는 다환식 카르바모일피리돈 유도체
|
AR057023A1
(es)
|
2005-05-16 |
2007-11-14 |
Gilead Sciences Inc |
Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
|
CA2616314A1
(en)
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
ES2569357T3
(es)
|
2005-10-27 |
2016-05-10 |
Shionogi & Co., Ltd. |
Derivado de carbamoilpiridona policíclico que tiene actividad inhibidora sobre integrasa de HIV
|
SG170795A1
(en)
|
2005-12-30 |
2011-05-30 |
Gilead Sciences Inc |
Methods for improving the pharmacokinetics of hiv integrase inhibitors
|
US7601844B2
(en)
|
2006-01-27 |
2009-10-13 |
Bristol-Myers Squibb Company |
Piperidinyl derivatives as modulators of chemokine receptor activity
|
EP1978960A4
(en)
|
2006-02-01 |
2009-12-02 |
Japan Tobacco Inc |
USE OF 6- (3-CHLORO-2-FLUORBENZYL) -1 - [(2S) -1-HYDROXY-3-METHYLBUTAN-2-YL [-7-METHOXY-4-OXO-1,4-DIHYDROCHINOLINE-3- CARBOXYLIC ACID OR SALT THEREOF FOR THE TREATMENT OF RETROVIRUS INFECTION
|
JP4669040B2
(ja)
|
2006-03-06 |
2011-04-13 |
日本たばこ産業株式会社 |
4−オキソキノリン化合物の製造方法
|
CN101437801B
(zh)
|
2006-03-06 |
2013-02-06 |
日本烟草产业株式会社 |
制备4-氧代喹啉化合物的方法
|
US7893055B2
(en)
|
2006-06-28 |
2011-02-22 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
CA2657034A1
(en)
|
2006-07-19 |
2008-01-24 |
University Of Georgia Research Foundation, Inc. |
Pyridinone diketo acids: inhibitors of hiv replication in combination therapy
|
SI2057165T1
(sl)
|
2006-09-07 |
2011-07-29 |
Ind Res Ltd Gracefield Res Ct |
Acikliäśni aminski zaviralci nukleozidnih fosforilaz in hidrolaz
|
AR063710A1
(es)
|
2006-09-12 |
2009-02-11 |
Gilead Sciences Inc |
Proceso para la preparacion de acido 6-(3-cloro-2-fluorbencil)-1-[(s)-1-hidroximetil-2-metilpropil]-7-metoxi-4-oxo-1, 4-dihidroquinolon-3-carboxilico como inhibidores de integrasa del hiv e intermediarios de sintesis del mismo y composiciones que lo comprenden.
|
US20100216834A1
(en)
|
2006-10-18 |
2010-08-26 |
Isaacs Richard C A |
Hiv integrase inhibitors
|
PL3150586T3
(pl)
|
2007-02-23 |
2020-06-01 |
Gilead Sciences, Inc. |
Modulatory farmakokinetycznych właściwości środków terapeutycznych
|
US20080280945A1
(en)
|
2007-05-09 |
2008-11-13 |
Sachin Lohani |
Crystalline forms of an HIV integrase inhibitor
|
SG182229A1
(en)
|
2007-06-29 |
2012-07-30 |
Gilead Sciences Inc |
Therapeutic compositions and the use thereof
|
WO2009006203A1
(en)
|
2007-06-29 |
2009-01-08 |
Gilead Sciences, Inc. |
Therapeutic compositions and the use thereof
|
WO2009018320A1
(en)
|
2007-07-31 |
2009-02-05 |
Limerick Biopharma, Inc. |
Pyrone analog compositions and methods
|
AR068403A1
(es)
|
2007-09-11 |
2009-11-18 |
Gilead Sciences Inc |
Proceso e intermediarios para la preparacion de inhibidores de integrasa
|
NZ585226A
(en)
|
2007-11-16 |
2012-08-31 |
Gilead Sciences Inc |
Inhibitors of human immunodeficiency virus replication
|
GB0803019D0
(en)
|
2008-02-19 |
2008-03-26 |
Btg Int Ltd |
Fluorinated compounds
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
WO2010011813A1
(en)
|
2008-07-23 |
2010-01-28 |
Alkermes, Inc. |
Complex of trospium and pharmaceutical compositions thereof
|
EP2465858B1
(en)
|
2008-07-25 |
2013-12-25 |
VIIV Healthcare Company |
Process for preparing a pyrido[1,2-a]pyrrolo[1',2':3,4]imidazo[1,2-d]pyrazine-8-carboxamide derivative
|
DK2320908T3
(en)
|
2008-07-25 |
2014-03-10 |
Viiv Healthcare Co |
DOLUTEGRAVIR prodrugs
|
WO2010011815A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
KR101772610B1
(ko)
|
2008-07-25 |
2017-09-12 |
비이브 헬쓰케어 컴퍼니 |
화합물
|
WO2010011819A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2010011818A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
CN106986823A
(zh)
|
2008-12-11 |
2017-07-28 |
盐野义制药株式会社 |
氨甲酰基吡啶酮hiv整合酶抑制剂的方法和中间体
|
BRPI0923217A2
(pt)
|
2008-12-11 |
2017-05-23 |
Glaxosmithkline Llc |
processos para a preparação de um composto de piridona, e para a preparação de uma forma cristalina, composto, sal ou um hidrato deste, forma cristalina de um sal de sódio ou um hidrato deste, e, composição farmacêutica.
|
TWI518084B
(zh)
|
2009-03-26 |
2016-01-21 |
鹽野義製藥股份有限公司 |
哌喃酮與吡啶酮衍生物之製造方法
|
EP2412708A4
(en)
|
2009-03-26 |
2014-07-23 |
Shionogi & Co |
SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
PT2444400T
(pt)
|
2009-06-15 |
2018-06-06 |
Shionogi & Co |
Derivado de carbamoilpiridona policíclico substituído
|
WO2011028044A2
(ko)
|
2009-09-02 |
2011-03-10 |
이화여자대학교 산학협력단 |
피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물
|
EP3351249A1
(en)
|
2010-01-27 |
2018-07-25 |
VIIV Healthcare Company |
Antiviral therapy
|
BR112012021595A2
(pt)
|
2010-02-26 |
2017-02-21 |
Japan Tobacco Inc |
"composto derivado de 1,3,4,8-tetra-hidro-2h-pirido[1,2-a]pirazina, suas composições, seus usos, agente anti-hiv, inibidor da integrase de hiv e embalagem comercial"
|
TWI582097B
(zh)
|
2010-03-23 |
2017-05-11 |
Viiv醫療保健公司 |
製備胺甲醯吡啶酮衍生物及中間體之方法
|
US20130165489A1
(en)
|
2010-05-03 |
2013-06-27 |
The Trustees Of The University Of Pennsylvania |
Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
|
AP2013006707A0
(en)
|
2010-07-02 |
2013-02-28 |
Gilead Sciences Inc |
2-Quinolinyl-acetic acid derivatives as HIV antiviral compounds
|
CN103140474A
(zh)
|
2010-07-02 |
2013-06-05 |
吉里德科学公司 |
治疗aids的萘-2-基乙酸衍生物
|
WO2012009009A2
(en)
|
2010-07-14 |
2012-01-19 |
Addex Pharma S.A. |
Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
|
ES2710609T3
(es)
|
2010-08-05 |
2019-04-26 |
Shionogi & Co |
Procedimiento de preparación de un compuesto que tiene actividad inhibidora de la integrasa del HIV
|
AU2011307087B2
(en)
|
2010-09-24 |
2016-11-10 |
Shionogi & Co., Ltd. |
Substituted polycyclic carbamoyl pyridone derivative prodrug
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
KR20140027295A
(ko)
|
2011-04-21 |
2014-03-06 |
길리애드 사이언시즈, 인코포레이티드 |
벤조티아졸 화합물 및 이들의 약학적 용도
|
US20140213553A1
(en)
|
2011-05-03 |
2014-07-31 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
WO2012151567A1
(en)
|
2011-05-05 |
2012-11-08 |
St. Jude Children's Research Hospital |
Pyrimidinone compounds and methods for preventing and treating influenza
|
ES2553449T3
(es)
|
2011-07-06 |
2015-12-09 |
Gilead Sciences, Inc. |
Compuestos para el tratamiento de VIH
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
PL2742051T3
(pl)
|
2011-09-14 |
2017-06-30 |
Mapi Pharma Limited |
Amorficzna postać soli sodowej dolutegrawiru
|
JP6163428B2
(ja)
|
2011-10-12 |
2017-07-12 |
塩野義製薬株式会社 |
インテグラーゼ阻害活性を有する多環性ピリドン誘導体
|
CN104114559B
(zh)
|
2011-12-12 |
2016-08-24 |
拜耳知识产权有限责任公司 |
氨基取代的咪唑并哒嗪
|
MX2014005002A
(es)
|
2012-04-20 |
2014-07-09 |
Gilead Sciences Inc |
Derivados de acido benzotiazol-6-il acetico y su uso para tratar una infeccion por vih.
|
WO2014008636A1
(en)
|
2012-07-11 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as hiv integrase inhibitors
|
US20150166520A1
(en)
|
2012-07-20 |
2015-06-18 |
Merck Sharp & Dohme Corp. |
Amido-substituted pyrimidinone derivatives useful for the treatment of hiv infection
|
WO2014018449A1
(en)
|
2012-07-25 |
2014-01-30 |
Merck Sharp & Dohme Corp. |
Substituted naphthyridinedione derivatives as hiv integrase inhibitors
|
BR112015002275A2
(pt)
|
2012-08-03 |
2017-07-04 |
Gilead Sciences Inc |
processos e intermediários para a preparação de inibidores da integrase
|
PE20150953A1
(es)
|
2012-11-08 |
2015-06-20 |
Bristol Myers Squibb Co |
Compuestos de piridilo sustituidos con heteroarilo utiles como moduladores de cinasa
|
CN104902905A
(zh)
|
2012-12-14 |
2015-09-09 |
葛兰素史克有限责任公司 |
药物组合物
|
WO2014099586A1
(en)
*
|
2012-12-17 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
4-pyridinonetriazine derivatives as hiv integrase inhibitors
|
EP2934482A4
(en)
|
2012-12-21 |
2016-07-20 |
Merck Sharp & Dohme |
ADMINISTRATIVE FORMULATIONS
|
US20140221355A1
(en)
|
2012-12-21 |
2014-08-07 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
SI3608325T1
(sl)
|
2012-12-21 |
2022-09-30 |
Gilead Sciences, Inc. |
Policiklične-karbamoilpiridonske spojine in njihova farmacevtska uporaba
|
KR20150102069A
(ko)
|
2012-12-27 |
2015-09-04 |
니뽄 다바코 산교 가부시키가이샤 |
치환된 스피로피리도[1,2-a]피라진 유도체 및 그의 HIV 인테그라제 저해제로서의 의약 용도
|
US9951079B2
(en)
|
2013-06-13 |
2018-04-24 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
|
NO2865735T3
(fi)
*
|
2013-07-12 |
2018-07-21 |
|
|
WO2015006731A1
(en)
*
|
2013-07-12 |
2015-01-15 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections
|
WO2015039348A1
(en)
*
|
2013-09-23 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
|
JP6081662B2
(ja)
|
2013-09-27 |
2017-02-15 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
Hivインテグラーゼ阻害薬として有用な置換されたキノリジン誘導体
|
US20150146340A1
(en)
|
2013-11-26 |
2015-05-28 |
Qualcomm Incorporated |
Multilayer ceramic capacitor including at least one slot
|
WO2015089847A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
|
EP3096763B1
(en)
|
2014-01-21 |
2019-12-25 |
Laurus Labs Limited |
Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
|